China Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics Market


  • Type: Rare Disease Area
  • Published : April 2021
  • Region: Asia
  • Country: China
  • Report ID : 1576

  • Format: PPT, PDF

China Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics Market: Segmented by Drug Type (C 5 Protein Inhibitors, Corticosteroids, Immunosuppressive Agents), Route of Administration (Oral, Parenteral), Distribution Channels (Hospital, Retail and Online Pharmacies)- Size, Share, Growth, Trends, and Forecasts (2019 – 2028)

SKU: 1576 Categories: ,

Report Overview

China Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics market size stood at around USD 0.0466 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Neuromyelitis optica spectrum disorder (NMOSD) is a severe inflammatory disease of the central nervous system (CNS) with preferential involvement of the optic nerve and spinal cord. NMOSD has an estimated annual incidence of 40,000 in China, with 60% of patients relapse in one year. The peak incidence was among those aged 45–65 years, mainly in females, the female to male ratio is 4.71:1. From 2015 to 2019, in China the prevalence of NMOSD in adults increased from 37200 to 39200. Approximately 80% of the NMOSD patient population are AQP4+ cases, in which a person’s own immune system attacks the astrocytes of the optic nerve, spinal cord and brainstem.

Market Drivers

China is a growing market for neuromyelitis optica spectrum disorder (NMOSD) disease due to increase in China’s prevalence rate (From 2015 to 2019, the prevalence of NMOSD in adults increased from 37200 to 3920) and improvement in healthcare facilities. In addition to these, the emergence of biologics and adoption of novel therapeutics are further pushing the market growth. Other factors that contribute to the growth of the market are increase in population and government initiatives.

Less trained expertise or technically skilled professionals coupled with high treatment cost significantly hinder the growth of neuromyelitis optica spectrum disorder (NMOSD) therapeutics market.

1. China Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics Market Overview
A. Market Size
2. Market Growth Drivers………………………………………………………………………
A. Improvement in Healthcare Facilities
B. Increase in Prevalence Rate
C. Emergence of Biologics
D. Adoption of Novel Therapeutics
3. Classification of Neuromyelitis Optica Spectrum Disorder (NMOSD) by Pathophysiology…….
A. Presence of Aquaporin 4 Autoantibody (AQP4-Ab)
B. Absence of Aquaporin 4 Autoantibody (AQP4-Ab)
4. Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics Market Segmentation….
A. By Drug Type
I. C 5 Protein Inhibitors
II. Corticosteroids
III. Immunosuppressive Agents
B. By Route of Administration
I. Oral
II. Parenteral
C. By Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Products Market Share
A. Market Analysis, Insights and Forecast – By Revenue Type
6. Competitive Landscape………………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………………
A. Alexion Company Overview, Product & Services, Strategies & Financials
B. Harbour Biomed Company Overview, Product & Services, Strategies & Financials
C. Roche Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………….
A. Policy Changes and Reimbursement Scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Neuromyelitis Optica Spectrum Disorder (NMOSD) Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Type:

On the basis of drug type, the China neuromyelitis optica spectrum disorder (NMOSD) therapeutics market can be segmented into C5 Protein Inhibitor, monoclonal antibodies, corticosteroids, immunosuppressive agents. For acute attacks, the standard treatment is high-dose intravenous corticosteroids, typically Methylprednisolone. Plasma exchange may be effective in patients who experience acute severe attacks that do not respond to intravenous corticosteroids.

By Route of Administration:

On the basis of route of administration, the China neuromyelitis optica spectrum disorder (NMOSD) therapeutics market can be segmented into oral and parenteral. Oral route of administration is dominating the market during the forecast period (2019-2028) due to its convenience and pain free administration. Parenteral route of administration is preferred in case of acute attacks.

By Distribution Channels:

On the basis of distribution channels, the China neuromyelitis optica spectrum disorder (NMOSD) therapeutics market can be segmented into retail, online and hospital pharmacies. During the forecast period (2019-2028) hospital pharmacies are the key distribution channels as they have a large patient base compared to other healthcare facilities and they also conduct various clinical trials. In addition to these the other factors that contribute to growth of the hospital pharmacies segment is increasing incidence (0.287/100,000 persons/year) of neuromyelitis optica spectrum disorder (NMOSD) and rising number of admissions of patients with the disease.

Major Players

Some of the key players in China neuromyelitis optica spectrum disorder (NMOSD) therapeutics market are Alexion Pharmaceuticals Inc; Viela Bio, Inc; F. Hoffmann-La Roche Ltd; Hansoh Pharma; Harbour Biomed (HBM) Holdings Limited; Accendatech Co. Ltd; Bio-Thera Solutions Ltd; RemeGen Biosciences.

Key players are adopting various strategies such as licensing agreement, strategic collaboration and partnerships. For instance, Viela Bio Enters Strategic Collaboration with Hansoh Pharma to Develop and Commercialize Inebilizumab in China for neuromyelitis optica spectrum disorder (NMOSD).

In April 2020, China’s Centre for Drug Evaluation (CDE) accepted a licensing application for ENSPRYNG (Satralizuma) for treatment of neuromyelitis optica spectrum disorder (NMOSD).

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements